| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |